Related Experiment Video
Updated: Aug 10, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Type beta transforming growth factor is an inhibitor of myogenic differentiation
Abstract:
We have investigated the effect of type beta transforming growth factor (TGF-beta) on the differentiation of skeletal muscle myoblasts. TGF-beta potently (ID50 approximately 10 pM) prevents established cell lines and primary cultures of rat and chicken embryo myoblasts from fusing into multinucleated myotubes. Inhibition of morphological differentiation by TGF-beta correlates with inhibition of the expression of muscle-specific mRNAs and proteins, strong induction of extracellular matrix type I collagen and fibronectin, and a marked tendency of the treated myoblasts to aggregate into densely multilayered arrays or clusters. Myogenic differentiation can resume after removal of TGF-beta from the medium. Examination of the time of action of TGF-beta shows that myoblasts stochastically reach a point beyond which they become insensitive to the inhibitory action of TGF-beta. This resistance of committed myoblasts to the inhibitory action of TGF-beta is not associated with any measurable change in the number or affinity of TGF-beta receptors in those cells. The results indicate that TGF-beta is a potent inhibitor of myogenesis and may regulate muscle development in vivo.
Insights
Type beta transforming growth factor (TGF-beta) strongly inhibits skeletal muscle cell differentiation. Muscle cells can resume differentiation after TGF-beta removal, independent of receptor changes.
Area of Science:
- Cell Biology
- Developmental Biology
- Biochemistry
Background:
- Skeletal muscle development involves myoblast differentiation and fusion.
- Growth factors play critical roles in regulating cell differentiation processes.
Purpose of the Study:
- To investigate the effect of type beta transforming growth factor (TGF-beta) on skeletal muscle myoblast differentiation.
- To understand the mechanism and timing of TGF-beta's action on myogenesis.
Main Methods:
- Utilized established cell lines and primary cultures of rat and chicken embryo myoblasts.
- Assessed myoblast fusion, expression of muscle-specific mRNAs and proteins, and extracellular matrix production.
- Examined the impact of TGF-beta removal and the timing of its inhibitory action.
Main Results:
- TGF-beta potently inhibited myoblast fusion into multinucleated myotubes (ID50 ~10 pM).
- Inhibition correlated with reduced muscle-specific gene expression and increased collagen/fibronectin.
- Myoblasts became refractory to TGF-beta inhibition at a specific differentiation point, independent of receptor levels.
Conclusions:
- TGF-beta is a potent inhibitor of myogenesis.
- TGF-beta may play a significant role in regulating muscle development in vivo.
- Myoblast commitment confers resistance to TGF-beta's inhibitory effects.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Forced Transdifferentiation
Artificial transdifferentiation occurs...